SEARCH

SEARCH BY CITATION

References

  • ALT, A., MCFADYEN, I.J., FAN, C.D., WOODS, J.H. & TRAYNOR, J.R. (2001). Stimulation of guanosine-5′-O-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of μ-opioid receptors and G protein. J. Pharmacol. Exp. Ther., 298, 116121.
  • ALVAREZ, V.A., ARTTAMANGKUL, S., DANG, V., SALEM, A., WHISTLER, J., VON ZASTROW, M., GRANDY, D.K. & WILLIAMS, J.T. (2002). μ-Opioid receptors: ligand-dependent activation of potassium conductance, desensitization, and internalization. J. Neurosci., 22, 57695776.
  • ARDEN, J.R., SEGREDO, V., WANG, Z., LAMEH, J. & SADEE, W. (1995). Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged μ-opioid receptor expressed in HEK 293 cells. J. Neurochem., 65, 16361645.
  • AVIDOR-REISS, T., NEVO, I., SAYA, D., BAYEWITCH, M. & VOGEL, Z. (1997). Opiate-induced adenylyl cyclase superactivation is isozyme-specific. J. Biol. Chem., 272, 50405047.
  • BAILEY, C.P., COUCH, D., JOHNSON, E., GRIFFITHS, K., KELLY, E. & HENDERSON, G. (2003). μ-Opioid receptor desensitization in mature rat neurons: lack of interaction between DAMGO and morphine. J. Neurosci., 23, 1051510520.
  • BLANCHET, C. & LUSCHER, C. (2002). Desensitization of μ-opioid receptor-evoked potassium currents: initiation at the receptor, expression at the effector. Proc. Natl. Acad. Sci. U.S.A., 99, 46744679.
  • BOHN, L.M., DYKSTRA, L.A., LEFKOWITZ, R.J., CARON, M.G. & BARAK, L.S. (2004). Relative opioid efficacy is determined by the complements of the G protein-coupled receptor desensitization machinery. Mol. Pharmacol., 66, 106112.
  • BOHN, L.M., GAINETDINOV, R.R., LIN, F., LEFKOWITZ, R.J. & CARON, M.G. (2000). μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence. Nature, 408, 720723.
  • BOHN, L.M., LEFKOWITZ, R.J., GAINETDINOV, R.R., PEPPEL, K, CARON, M.G. & LIN, F.T. (1999). Enhanced morphine analgesia in mice lacking β-arrestin 2. Science, 286, 24952498.
  • BORGLAND, S.L., CONNOR, M., OSBORNE, P.B., FURNESS, J.B. & CHRISTIE, M.J. (2003). Opioid agonists have different efficacy profiles for G protein activation, rapid desensitization, and endocytosis of mu-opioid receptors. J. Biol. Chem., 278, 1877618784.
  • BUSHELL, T., ENDOH, T., SIMEN, A.A., REN, D., BINDOKAS, V.P. & MILLER, R.J. (2002). Molecular components of tolerance to opiates in single hippocampal neurons. Mol. Pharmacol., 61, 5564.
  • CELVER, J., XU, M., JIN, W., LOWE, J. & CHAVKIN, C. (2004). Distinct domains on the μ-opioid receptor control uncoupling and internalization. Mol. Pharmacol., 65, 528537.
  • CEN, B., XIONG, Y., MA, L. & PEI, G. (2001). Direct and differential interaction of β-arrestins with the intracellular domains of different opioid receptors. Mol. Pharmacol., 59, 758764.
  • CHAKRABARTI, S., LAW, P.-Y. & LOW, H.H. (1998). Distinct differences between morphine- and [D-Ala2,N-MePhe4,Gly-ol5]-enkephalin-μ-opioid receptor complexes demonstrated by cyclic AMP-dependent protein kinase phosphorylation. J. Neurochem., 71, 231239.
  • CHAKRABARTI, S., PRATHER, P., YU, Y., LAW, P.-Y. & LOW, H.H. (1995). Expression of the μ-opioid receptor in CHO cells: ability of μ-opioid ligands to promote α-azidoanilido[32P]GTP labeling of multiple G protein α subunits. J. Neurochem., 64, 25342543.
  • CHRISTIE, M.J., WILLIAMS, J.T. & NORTH, R.A. (1987). Cellular mechanisms of opioid tolerance: studies in single brain neurons. Mol. Pharmacol., 32, 633638.
  • CHRISTOPOULOS, A. & EL-FAKAHANY, E.E. (1999). Qualitative and quantitative assessment of relative agonist efficacy. Biochem. Pharmacol., 58, 735748.
  • CHUANG, H.H., YU, Y., JAN, Y.N. & JAN, L.Y. (1998). Evidence that the nucleotide exchange and hydrolysis cycle of G proteins causes acute desensitization of G protein-gated inward rectifier K+ channels. Proc. Natl. Acad. Sci. U.S.A., 95, 1172711732.
  • CLARK, M.J., HARRISON, C., ZHONG, H., NEUBIG, R.R. & TRAYNOR, J.R. (2003). Endogenous RGS protein action modulates μ-opioid signalling through Gαo. J. Biol. Chem., 278, 94189425.
  • CLARK, R.B., KNOLL, B.J. & BARBER, R. (1999). Partial agonists and G protein-coupled receptor desensitization. Trends Pharmacol. Sci., 20, 279286.
  • CONNOR, M., BORGLAND, S.L. & CHRISTIE, M.J. (1999). Continued morphine modulation of calcium channel currents in acutely isolated locus coeruleus neurons from morphine-dependent rats. Br. J. Pharmacol., 128, 15611569.
  • CONNOR, M. & CHRISTIE, M.J. (1999). Opioid receptor signalling mechanisms. Clin. Exp. Pharmacol. Physiol., 26, 493499.
  • CONNOR, M., VAUGHAN, C.W., CHIENG, B. & CHRISTIE, M.J. (1996). Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro. Br. J. Pharmacol., 119, 16141618.
  • DENG, H.B., YU, Y., PAK, Y., O'DOWD, B.F., GEORGE, S.R., SURRATT, C.K., UHL, G.R. & WANG, J.B. (2000). Role for the C-terminus in agonist-induced μ-opioid receptor phosphorylation and desensitization. Biochemistry, 39, 54925499.
  • DENG, H.B., YU, Y., WANG, H., GUANG, W. & WANG, J.B. (2001). Agonist-induced μ opioid receptor phosphorylation and functional desensitization in rat thalamus. Brain Res., 898, 204214.
  • EL KOUHEN, R., BURD, A.L., ERICKSON-HERBRANDSON, L.J., CHANG, C.-Y., LAW, P.-Y. & LOH, H.H. (2001). Phosphorylation of Ser363, Thr370 and Ser375 residues within the carboxyl tail differentially regulates μ-opioid receptor internalization. J. Biol. Chem., 276, 1277412780.
  • EL KOUHEN, R., MAESTRI-EL KOUHEN, O., LAW, P.-Y. & LOW, H.H. (1999). The absence of a direct correlation between the loss of [D-Ala2,N-MePhe4,Gly5-ol]enkephalin inhibition of adenylyl cyclase activity and agonist-induced μ-opioid receptor phosphorylation. J. Biol. Chem., 274, 92079215.
  • ELLIOT, J., GUO, L. & TRAYNOR, J.R. (1997). Tolerance to μ-opioid agonists in human neuroblastoma SH-SY5Y cells as determined by changes in guanosine-5′-O-(3-[35S]-thio)triphosphate binding. Br. J. Pharmacol., 121, 14221428.
  • FINN, A.K. & WHISTLER, J.L. (2001). Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of withdrawal. Neuron, 32, 829839.
  • FIORELLO, C.D. & WILLIAMS, J.T. (1996). Opioid desensitization: interactions with G-protein-coupled receptors in the locus coeruleus. J. Neurosci., 16, 14791485.
  • FREDERICKS, Z.L., PITCHER, J.L. & LEFKOWITZ, R.J. (1996). Identification of the G protein-coupled receptor kinase phosphorylation sites in the human β2-adrenergic receptor. J. Biol. Chem., 271, 1379613803.
  • GHANOUNI, P., GRYCZYNSKI, Z., STEENHUIS, J.J., LEE, T.W., FARRENS, D.L., LAKOWICZ, J.R. & KOBILKA, B.K. (2001). Functionally different agonists induce distinct conformations in the G protein coupling domain of the β2 adrenergic receptor. J. Biol. Chem., 276, 2443324436.
  • GUREVICH, V.V. & GUREVICH, E.V. (2004). The molecular acrobatics of arrestin activation. Trends Pharmacol. Sci., 25, 105111.
  • HABERSTOCK-DEBIC, H., WEIN, M., BARROT, M., COLAGO, E.E.O., RAHMAN, Z., NEVE, R.L., PICKEL, V.M., NESTLER, E.J., VON ZASTROW, M. & SVINGOS, A.L. (2003). Morphine acutely regulates opioid receptor trafficking selectively in dendrites of nucleus accumbens neurons. J. Neurosci., 23, 43244332.
  • HACK, S.P., VAUGHAN, C.W. & CHRISTIE, M.J. (2003). Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro. Neuropharmacology, 45, 575584.
  • HARRIS, G.C. & WILLIAMS, J.T. (1991). Transient, homologous μ-opioid receptor desensitization in rat locus coeruleus neurons. J. Neurosci., 11, 25742581.
  • HE, L., FONG, J., VON ZASTROW, M. & WHISTLER, J.L. (2002). Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell, 108, 271282.
  • INGRAM, S., WILDING, T.J., MCCLESKEY, E.W. & WILLIAMS, J.T. (1997). Efficacy and kinetics of opioid action on acutely dissociated neurons. Mol. Pharmacol., 52, 136143.
  • INGRAM, S.L., VAUGHAN, C.W., BAGLEY, E.E., CONNOR, M. & CHRISTIE, M.J. (1998). Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. J. Neurosci., 18, 1026910276.
  • KEITH, D.E., ANTON, B., MURRAY, S.R., ZAKI, P.A., CHU, P.C., LISSIN, D.V., MONTEILLET-AGIUS, G., STEWART, P.L., EVANS, C.J. & VON ZASTROW, M. (1998). μ-Opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain. Mol. Pharmacol., 53, 377384.
  • KEITH, D.E., MURRAY, S.R., ZAKI, P.A., CHU, P.C., LISSIN, D.V., KANG, L., EVANS, C.J. & VON ZASTROW, M. (1996). Morphine activates opioid receptors without causing their rapid internalization. J. Biol. Chem., 271, 1902119024.
  • KENAKIN, T. (2002). Drug efficacy at G protein-coupled receptors. Annu. Rev. Pharmacol. Toxicol., 42, 349379.
  • KOCH, T., BRANDENBURG, L.-O., LIANG, Y., SCHULZ, S., BEYER, A., SCHRODER, H. & HOLLT, V. (2004). Phospholipase D2 modulates agonist-induced μ-opioid receptor desensitization and resensitization. J. Neurochem., 88, 680688.
  • KOCH, T., BRANDENBURG, L.-O., SCHULZ, S., LIANG, Y., KLEIN, J. & HOLLT, V. (2003). ADP-ribosylation factor-dependent phospholipase D2 activation is required for agonist-induced μ-opioid receptor endocytosis. J. Biol. Chem., 278, 99799986.
  • KOCH, T., KROSLAK, T., MAYER, P., RAULF, E. & HOLLT, V. (1997). Site mutation in the rat μ-opioid receptor demonstrates the involvement of calcium/calmodulin-dependent protein kinase II in agonist-mediated desensitization. J. Neurochem., 69, 17671770.
  • KOCH, T., SCHULZ, S., PFEIFFER, M., KLUZTNY, M., SCHRODER, H., KAHL, E. & HOLLT, V. (2001). C-terminal splice variants of the mouse μ-opioid receptor differ in morphine-induced internalization and receptor resensitization. J. Biol. Chem., 276, 3140831414.
  • KOCH, T., SCHULZ, S., SCHRODER, H., WOLF, R., RAULF, E. & HOLLT, V. (1998). Carboxyl-terminal splicing of the rat μ opioid receptor modulates agonist-mediated internalization and receptor resensitization. J. Biol. Chem., 273, 1365213667.
  • KOVOOR, A., CELVER, J.P., WU, A. & CHAVKIN, C. (1998). Agonist induced homologous desensitization of μ-opioid receptors is mediated by G protein-coupled receptor kinases and is dependent on agonist efficacy. Mol. Pharmacol., 54, 704711.
  • KOVOOR, A., HENRY, D.J. & CHAVKIN, C. (1995). Agonist-induced desensitization of the mu opioid receptor-coupled potassium channel (GIRK1). J. Biol. Chem., 270, 589595.
  • KOVOOR, A., NAPPEY, V., KIEFFER, B.L. & CHAVKIN, C. (1997). μ and δ opioid receptors are differentially desensitized by the co-expression of β-adrenergic receptor kinase 2 and β-arrestin 2 in Xenopus oocytes. J. Biol. Chem., 272, 2760527611.
  • KRUEGER, K.M., DAAKA, Y., PITCHER, J.A. & LEFKOWITZ, R.J. (1997). The role of sequestration in G protein-coupled receptor resensitization. J. Biol. Chem., 272, 58.
  • LAW, P.-Y., ERICKSON, L.J., EL-KOUHEN, R., DICKER, L., SOLBERG, J., WANG, W., MILLER, E., BURD, A.L. & LOH, H.H. (2000). Receptor density and recycling affect the rate of agonist-induced desensitization of μ-opioid receptor. Mol. Pharmacol., 58, 388398.
  • LEANEY, J.L., BENIANS, A., BROWN, S., NOBLES, M., KELLEY, D. & TINKER, A. (2004). Rapid desensitization of G protein-gated inwardly rectifying K+ currents is determined by G protein cycle. Am. J. Physiol. Cell Physiol., 287, C182C191.
  • LI, A.H. & WANG, H.-L. (2001). G protein-coupled receptor kinase 2 mediates μ-opioid receptor desensitization in GABAergic neurons of the nucleus raphe magnus. J. Neurochem., 77, 435444.
  • LI, J., XIANG, B., SU, W., ZHANG, X., HAUNG, Y. & MA, L. (2003). Agonist-induced formation of opioid receptor-G protein-coupled receptor kinase (GRK)-G(βγ) complex on membrane is required for GRK2 function in vivo. J. Biol. Chem., 278, 3021930226.
  • LI, L.Y. & CHANG, K.J. (1996). The stimulatory effect of opioids on mitogen-activated protein kinase in Chinese hamster ovary cells transfected to express mu-opioid receptors. Mol. Pharmacol., 50, 599602.
  • LOHSE, M.J., BENOVIC, J.L., CARON, M.G & LEFKOWITZ, R.J. (1990). Multiple pathways of rapid β2-adrenergic receptor desensitization. Delineation with specific inhibitors. J. Biol. Chem., 265, 32023211.
  • LOWE, J.D., CELVER, J.P., GUREVICH, V.V. & CHAVKIN, C.C. (2002). μ-Opioid receptors desensitise less rapidly than δ-opioid receptors due to less efficient activation of arrestin. J. Biol. Chem., 277, 1572915735.
  • MASSOTTE, D., BRILLET, K., KIEFFER, B.L. & MILLIGAN, G. (2002). Agonists activate Gi1α or Gi2α fused to the human mu opioid receptor differently. J. Neurochem., 82, 13721382.
  • MCLAUGHLIN, J.P., MYERS, L.C., ZAREK, P.E., CARON, M.G., LEFKOWITZ, R.J., CZYZYK, T.A. & PINTAR, J.E. (2004). Prolonged kappa opioid receptor phosphorylation mediated by G protein receptor kinase underlies sustained analgesic tolerance. J. Biol. Chem., 279, 18101818.
  • MCQUAY, H. (1999). Opioids in pain management. Lancet, 353, 22292232.
  • NOMURA, K., REUVENY, E. & NARAHASHI, T. (1994). Opioid inhibition and desensitization of calcium channel currents in rat dorsal root ganglion neurons. J. Pharmacol. Exp. Ther., 270, 466474.
  • OAKLEY, R.H., LAPORTE, S.A., HOLT, J.A., CARON, M.G. & BARAK, L.S. (2000). Differential affinities of visual arrestin, βarrestin1, and βarrestin2 for G protein-coupled receptors delineate two major classes of receptors. J. Biol. Chem., 275, 1720117210.
  • OSBORNE, P.B. & WILLIAMS, J.T. (1995). Characterization of acute homologous desensitization of μ-opioid receptor-induced currents in locus coeruleus neurones. Br. J. Pharmacol., 115, 925932.
  • PAK, Y., O'DOWD, B.F., WANG, J.B. & GEORGE, S.R. (1999). Agonist-induced, G protein-dependent and -independent down regulation of the μ opioid receptor. J. Biol. Chem., 274, 2761027616.
  • POLAKIEWICZ, R.D., SCHIEFERL, S.M., DORNER, L.F., KANSRA, V. & COMB, M.J. (1998). A mitogen-activated protein kinase pathway is required for μ-opioid receptor desensitization. J. Biol. Chem., 273, 1240212406.
  • SAMORISKI, G.M. & GROSS, R.A. (2000). Functional compartmentalization of opioid desensitization in primary sensory neurons. J. Pharmacol. Exp. Ther., 294, 500509.
  • SCHULZ, R., WEHMEYER, A. & SCHULZ, K. (2002). Opioid receptor types selectively cointernalize with G protein-coupled receptor kinases 2 and 3. J. Pharmacol. Exp. Ther., 300, 376384.
  • SELLEY, D.E., SIM, L.J., XIAO, R., LIU, Q. & CHILDERS, S.R. (1997). μ-Opioid-receptor stimulated guanosine-5′-O-(γ-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy. Mol. Pharmacol., 51, 8796.
  • SIM, L.J., SELLEY, D.E., DWORKIN, S.I. & CHILDERS, S.R. (2000). Effects of chronic morphine administration on mu opioid receptor-stimulated [35S]GTPγS autoradiography in rat brain. J. Neurosci., 16, 26842692.
  • STERNINI, C., SPANN, M., ANTON, B., KEITH JR, D.E., BUNNET, N.W., VON ZASTROW, M., EVANS, C. & BRECHA, N.C. (1996). Agonist-selective endocytosis of μ opioid receptor by neurons in vivo. Proc. Natl. Acad. Sci. U.S.A., 93, 94219426.
  • STICKLE, D. & BARBER, R. (1983). Evidence for the role of epinephrine binding frequency in activation of adenylate cyclase. Mol. Pharmacol., 36, 437445.
  • SWAMINATH, G., XIANG, Y., LEE, T.W., STEENHUIS, J., PARNOT, C. & KOBILKA, B.K. (2004). Sequential binding of agonists to the β2-adrenoceptor. J. Biol. Chem., 279, 686691.
  • TANOWITZ, M. & VON ZASTROW, M. (2003). A novel endocytic recycling signal that distinguishes the membrane trafficking of naturally occurring opioid receptors. J. Biol. Chem., 278, 4597845986.
  • TRAPAIDZE, N., GOMES, I., CVEJIC, S., BANSINATH, M. & DEVI, L.A. (2000). Opioid receptor endocytosis and activation of MAP kinase pathway. Mol. Brain Res., 76, 220228.
  • TRZECIAKOWSKI, J.P. (1999). Stimulus amplification, efficacy, and the operational model. Part I – binary complex occupancy mechanisms. J. Theor. Biol., 198, 329346.
  • VILARDAGA, J.P., BUNEMANN, M., KRASEL, C., CASTRO, M. & LOHSE, M.J. (2003). Measurement of the millisecond activation switch of G protein-coupled receptors in living cells. Nat. Biotechnol., 21, 807812.
  • VON ZASTROW, M., SVINGOS, A., HABERSTOCK-DEBIC, H. & EVANS, C. (2003). Regulated endocytosis of opioid receptors: cellular mechanisms and proposed roles in physiological adaptation to opiate drugs. Curr. Opin. Neurobiol., 13, 348353.
  • WALDHOER, M., BARTLETT, S.E. & WHISTLER, J.L. (2004). Opioid receptors. Annu. Rev. Biochem., 73, 953990.
  • WANG, H.-L., CHANG, W.-T., HSU, C.-Y., HUANG, P.-C., CHOW, Y.-W. & LI, A.H. (2002). Identification of two C-terminal amino acids, Ser355 and Thr357, required for short-term homologous desensitization of μ-opioid receptors. Biochem. Pharmacol., 64, 257266.
  • WHISTLER, J.L., CHUANG, H.-H., CHU, P., JAN, L.Y. & VON ZASTROW, M. (1999). Functional dissociation of μ-opioid receptor signalling and endocytosis: implications for the biology of opiate tolerance and addiction. Neuron, 23, 737746.
  • WHISTLER, J.L. & VON ZASTROW, M. (1998). Morphine activated opioid receptors elude desensitization by β-arrestin. Proc. Natl. Acad. Sci. U.S.A., 95, 99149919.
  • WILDING, T.J., WOMACK, M.D. & MCCLESKEY, E.W. (1995). Fast, local signal transduction between the mu opioid receptor and Ca2+ channels. J. Neurosci., 15, 41244132.
  • WOOLF, P.J. & LINDERMAN, J.J. (2003). Untangling ligand induced activation and desensitization of G protein-coupled receptors. Biophys. J., 84, 313.
  • YU, Y., ZHANG, L., YIN, X., SUN, H., UHL, G.R. & WANG, J.B. (1997). μ-Opioid receptor phosphorylation, desensitization and ligand efficacy. J. Biol. Chem., 272, 2886928874.
  • ZHANG, J., FERGUSON, S.S.G., BARAK, L.S., BODDULURI, S.R., LAPORTE, S.A., LAW, P.-Y. & CARON, M.G. (1998). Role for G protein-coupled receptor kinase in agonist-specific regulation of μ-opioid receptor responsiveness. Proc. Natl. Acad. Sci. U.S.A., 95, 71577162.
  • ZHANG, L., YU, Y., MACKIN, S., WEIGHT, F.F., UHL, G.R. & WANG, J.B. (1996). Differential μ opiate receptor phosphorylation and desensitization induced by agonists and phorbol esters. J. Biol. Chem., 271, 1144911454.
  • ZHONG, H., WADE, S.M., WOOLF, P.J., LINDERMAN, J.J., TRAYNOR, J.R. & NEUBIG, R.R. (2003). A spatial focusing model for G protein signals. J. Biol. Chem., 278, 72787284.